Table 2.
Levels (median/interquartile range IQR) of antinuclear-associated autoantibodies in serum and in corresponding Immune complexes (IC).
| ANA | Serum | IC | ||||
|---|---|---|---|---|---|---|
| Sudan, median/IQR | Sweden, median/IQR | P | Sudan, median/IQR | Sweden, median/IQR | P | |
| SSA/Ro52 | 16.0/10.0–75.5 | 17.0/9.0–70.0 | 0.8 | 2.9/1.5–9.8 | 2.4/1.2–6.0 | 0.07 |
| SSA/Ro60 | 2.0/0–106.0 | 3.0/1.0–111.0 | 0.2 | 1.5/0.6–20.2 | 1.3/0.5–15.3 | 0.7 |
| SSB/La | 2.0/1.0–13.0 | 2.0/1.0–15.0 | 0.6 | 1.1/0.6–1.9 | 0.8/0.4–1.9 | 0.02 |
| Sm | 1.0/0–3.5 | 1.0/1.0–4.0 | 0.0008 | 0.5/0.2–0.8 | 0.3/0.2–0.4 | < 0.0001 |
| Sm/U1RNP | 1.0/0–10.0 | 1.0/1.0–10.0 | 0.2 | 3.7/1.8–7.2 | 2.0/1.2–4.0 | < 0.0001 |
| U1RNP | 6.0/3.0–25.5 | 7.0/3.0–27.0 | 0.9 | 1.0/0.6–2.4 | 0.6/0.4–1.4 | 0.0005 |
| dsDNA | 14.0/6.0–110.5 | 28.0/11.0–166.0 | 0.001 | 32.1/15.5–57.7 | 12.4/6.8–25.9 | < 0.0001 |
| Histone | 5.0/3.0–12.0 | 6.0/3.0–15.0 | 0.2 | 4.0/2.1–7.6 | 1.9/1.0–3.5 | < 0.0001 |
| Ribosomal P | 1.0/0.6–3.0 | 2.0/1.0–5.0 | 0.0006 | 1.7/1.0–3.0 | 1.4/0.8–2.2 | 0.005 |
| PCNA | 5.0/3.0–10.5 | 5.0/3.0–10.0 | 0.6 | 11.1/6.7–18.9 | 7.0/4.0–12.4 | < 0.0001 |
Significant P values are depicted in bold and underlined to indicate higher levels in Sudanese patients.